ESC Premium Access

Natural history and prognostic significance of pulmonary hypertension in patients undergoing TAVR for severe aortic stenosis

Congress Presentation

About the speaker

Doctor Brunilda Alushi

Heart Center Alter Hof, Munich (Germany)
0 follower

4 more presentations in this session

State of the Art: TAVI indications and adoption: a dynamic field

Speaker: Professor B. Prendergast (London, GB)


Thirty-day and long-term outcomes after transcatheter aortic valve implantation from first-in-man to nowadays: 15 years experience of a pioneered center.

Speaker: Professor E. Durand (Rouen, FR)


Worse outcome of patients with normal ejection fraction but low-gradient aortic valve stenosis after transcatheter aortic valve implantation (TAVI)

Speaker: Doctor U. Fischer-Rasokat (Bad Nauheim, DE)


TAVI complications: incidence, trends and management.

Speaker: Professor A. Chieffo (Milan, IT)


Access the full session

TAVI: a new standard for aortic valve replacement?

Speakers: Doctor B. Alushi, Professor B. Prendergast, Professor E. Durand, Doctor U. Fischer-Rasokat, Professor A. Chieffo

About the event


ESC Congress 2017

26 August - 30 August 2017

Sessions Presentations

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb